CAS 863031-21-4
:Azilsartan medoxomil
Description:
Azilsartan medoxomil is an angiotensin II receptor antagonist used primarily in the treatment of hypertension. It is a prodrug that is converted in the body to its active form, azilsartan, which selectively blocks the angiotensin II type 1 receptor, leading to vasodilation and reduced blood pressure. The chemical formula of azilsartan medoxomil reflects its complex structure, which includes a biphenyl group and a carboxylic acid moiety. This compound is characterized by its high potency and long duration of action, making it effective for once-daily dosing. Azilsartan medoxomil is typically administered orally and is well-absorbed, with its pharmacokinetics influenced by factors such as food intake. Common side effects may include dizziness, fatigue, and gastrointestinal disturbances. As with other antihypertensive agents, it is important to monitor renal function and electrolyte levels during treatment. Overall, azilsartan medoxomil represents a significant advancement in the management of high blood pressure, providing an effective option for patients requiring antihypertensive therapy.
Formula:C30H24N4O8
InChI:InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36)
InChI key:InChIKey=QJFSABGVXDWMIW-UHFFFAOYSA-N
SMILES:C(N1C=2C(N=C1OCC)=CC=CC2C(OCC=3OC(=O)OC3C)=O)C4=CC=C(C=C4)C5=C(C=CC=C5)C=6NC(=O)ON6
Synonyms:- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
- 1-[[2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 1H-Benzimidazole-7-carboxylic acid, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- Edarbi
- Ipreziv
- Tak 491
- Azilsartan medoxomil
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
Azilsartan Medoxomil
CAS:Formula:C30H24N4O8Color and Shape:White To Off-White SolidMolecular weight:568.54(5-Methyl-2-Oxo-1,3-Dioxol-4-Yl)Methyl 2-Ethoxy-1-((2'-(5-Oxo-4,5-Dihydro-1,2,4-Oxadiazol-3-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-1H-Benzo[D]Imidazole-7-Carboxylate
CAS:(5-Methyl-2-Oxo-1,3-Dioxol-4-Yl)Methyl 2-Ethoxy-1-((2'-(5-Oxo-4,5-Dihydro-1,2,4-Oxadiazol-3-Yl)-[1,1'-Biphenyl]-4-Yl)Methyl)-1H-Benzo[D]Imidazole-7-CarboxylatePurity:98%Molecular weight:568.53g/molAzilsartan medoxomil
CAS:Formula:C30H24N4O8Purity:≥ 98.0%Color and Shape:White to off-white powderMolecular weight:568.53Azilsartan Medoxomil
CAS:Azilsartan Medoxomil (TAK-491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adultsFormula:C30H24N4O8Purity:99.83%Color and Shape:SolidMolecular weight:568.53Azilsartan Medoxomil
CAS:Controlled Product<p>Applications Azilsartan medoxomil is a long-acting angiotensin II receptor blocker (ARB) that is used to lower hypertension. When Azilsartan medoxomil enters the gastrointestinal tract, it is rapidly converted to its active form, Azilsartan (A926900).<br>References Baker, W. & White, W.: Pharmacotherapy, 45, 1506 (2011); Cushman, W., et al.: Hypertension, 60, 310 (2012); Lastra, G., et al.: Cardio. Med. 3, 154 (2013); Miura, S., et al.: Hypertens. Res., 36, 134 (2012); Rakugi, H., et al.: Hypertens. Res., 35, 552 (2012)<br></p>Formula:C30H24N4O8Color and Shape:NeatMolecular weight:568.53Azilsartan Medoxomil-D5
CAS:Controlled ProductFormula:C30D5H19N4O8Color and Shape:NeatMolecular weight:573.564Azilsartan medoxomil
CAS:<p>Azilsartan medoxomil is an antihypertensive drug, which is a prodrug of the angiotensin II receptor blocker azilsartan. It is synthesized through a chemical process involving the modification of the medoxomil ester, converting it into its active form upon absorption in the gastrointestinal tract. The primary mode of action of azilsartan medoxomil involves selective antagonism of the angiotensin II type 1 (AT1) receptor. By blocking the effects of angiotensin II—a potent vasoconstrictor—azilsartan medoxomil effectively reduces vascular resistance, leading to decreased blood pressure.</p>Formula:C30H24N4O8Purity:Min. 95%Color and Shape:White PowderMolecular weight:568.53 g/mol






